1. Synthesis and biological evaluation of some novel 6-aryl-2-(p-sulfamylphenyl)-4,5-dihydropyridazin-3(2H)-ones as anti-cancer, antimicrobial, and anti-inflammatory agents;Ahmad;J. Enzyme Inhib. Med. Chem.,2010
2. Design and synthesis of pyridazinone-based 5-HT2C agonists;Allerton;Bioorg. Med. Chem. Lett.,2009
3. Unexpected inversions in asymmetric reactions: reactions with chiral metal complexes, chiral organocatalysts, and heterogeneous chiral catalysts;Bartók;Chem. Rev.,2010
4. Stereodivergent catalysis;Beletskaya;Chem. Rev.,2018
5. Berthel, S., Haynes, N.-E., Kester, R.F., McDermott, L., Qian, Y., Sarabu, R., Scott, N., and Tilley, J. (2009). Pyridazinones as glucokinase activators and their preparation, pharmaceutical compositions and use in the treatment of metabolic disorders.WO 2009127544 US 20090264434.